Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic irbesartan product from Camber Pharmaceuticals through an original ANDA. The product is indicated for hypertension an…
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Original Application for IRBESARTAN, authorizing the marketing of the generic irbesartan. The approv…
-
FDA approval · 2012-09-24FDA Approved: LOSARTAN POTASSIUM — Original Application (Micro Labs Limited)
FDA approved Losartan potassium under an Original Application for Micro Labs Limited.
-
FDA approval · 2012-09-18FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approves Jubilant Cadista's Losartan Potassium tablets 25 mg as an original ANDA, providing a generic version of losartan for hypert…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure [Phase 2]
Phase 2 results from Tehran University of Medical Sciences evaluate spironolactone in combination therapy for reducing proteinuria, preservi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine. [Phase 1]
A completed Phase 1 trial evaluating ABT-614 for safety, tolerability, and kidney function in adults with type 2 diabetes mellitus and chron…
-
FDA approval · 2012-08-13FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Zestril (lisinopril) submitted by Upsher-Smith Laboratories.
-
FDA approval · 2012-07-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for losartan potassium submitted by Quallent Pharmaceuticals Health LLC under ANDA078243.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating whether milk thistle extract can protect kidney function in patients with diabetic nephropathy. The stud…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Nitric Oxide (NO) Activity and Diabetic Nephropathy [Phase 2, Phase 3]
Phase 2 and Phase 3 trials investigating nitric oxide activity in diabetic nephropathy have completed.
-
FDA approval · 2012-05-30FDA Approved: LOSARTAN POTASSIUM — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's Losartan Potassium as an original-application generic (ANDA 202230), granting marketing appr…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Eplerenone, ACE Inhibition and Albuminuria [Phase 2]
Phase 2 trial update evaluating eplerenone in combination with ACE inhibition on albuminuria in diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease [Phase 3]
Phase 3 trial evaluating omega-3 fatty acid supplementation for diabetes-related kidney disease has completed.
-
FDA approval · 2012-04-27FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for ATACAND (candesartan cilexetil). This action updates the drug's labeling as p…
-
CLINICAL_TRIALS research · 2012-04-19Clinical Trial Update: The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus [NA]
A completed clinical trial assessing the effects of green tea or cocoa extracts on endothelial dysfunction in patients with diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy [Phase 4]
Phase 4 trial comparing a vitamin D analogue with placebo in patients with Type 1 diabetes mellitus and diabetic nephropathy, assessing p-NT…
-
CLINICAL_TRIALS research · 2012-03-29Clinical Trial Update: Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration [NA]
Overview of an ongoing clinical trial evaluating mycophenolate mofetil, carnitine, and a PDE5 inhibitor as potential treatments to slow dete…
-
FDA approval · 2012-01-18FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2012-01-03FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for losartan potassium from Quallent Pharmaceuticals Health LLC for an existing generic product.
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy [Phase 1]
Phase 1 trial update assessing whether sevelamer carbonate reduces oxidative stress in patients with diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Antialbuminuric Effects of Valsartan and Lisinopril [Phase 4]
Phase 4 trial update evaluating the antialbuminuric effects of valsartan and lisinopril in hypertension and early diabetic nephropathy; the …
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of CTP-499 in diabetic nephropathy. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy [NA]
Completed clinical trial evaluating rosiglitazone's effects on renal hemodynamics and proteinuria in adults with type 2 diabetes and overt d…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)
Clinical trial evaluating whether losartan protects kidney function in hypertensive diabetic patients with microalbuminuria has completed; r…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy [Phase 4]
A Phase 4 clinical trial from Shanghai Jiao Tong University School of Medicine is evaluating whether a low-protein diet supplemented with ke…